EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

Susana Otero-Romero iD, Christine Lebrun-Frénay iD, Saúl Reyes, Maria Pia Amato, Magda Campins, Mauricio Farez iD, Massimo Filippi iD, Yael Hacohen, Bernhard Hemmer iD, Rosa Juuti, Melinda Magyari iD, Celia Oreja-Guevara iD and 3 more

European Journal of Neurology · 2023-08 · 30 (8) · 2144-2176

DOI: 10.1111/ene.15809 ↗

At a glance

Journal article in European Journal of Neurology, published online on 2023-06-09. Written by Susana Otero-Romero and 14 co-authors. Institution: Preventive Medicine and Epidemiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. Major MEDLINE topics: Multiple Sclerosis, Neurology. Cited 16 times so far (Crossref); 104 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and purpose With the new highly active drugs available for people with multiple sclerosis (pwMS), vaccination becomes an essential part of the risk management strategy. We aimed to develop a European evidence‐based consensus for the vaccination strategy of pwMS who are candidates for disease‐modifying therapies (DMTs).

Methods

This work was conducted by a multidisciplinary working group using formal consensus methodology. Clinical questions (defined as population, interventions and outcomes) considered all authorized DMTs and vaccines. A systematic literature search was conducted and quality of evidence was defined according to the Oxford Centre for Evidence‐Based Medicine Levels of Evidence. The recommendations were formulated based on the quality of evidence and the risk–benefit balance.

Results

Seven questions, encompassing vaccine safety, vaccine effectiveness, global vaccination strategy and vaccination in subpopulations (pediatric, pregnant women, elderly and international travelers) were considered. A narrative description of the evidence considering published studies, guidelines and position statements is presented. A total of 53 recommendations were agreed by the working group after three rounds of consensus.

Conclusion

This first European consensus on vaccination in pwMS proposes the best vaccination strategy according to current evidence and expert knowledge, with the goal of homogenizing the immunization practices in pwMS.

Subjects

MeSH terms (MEDLINE)

Multiple SclerosisNeurologyPregnancyFemaleHumansChildAgedImmunizationVaccination

Author keywords

consensusdisease-modifying therapyinfectionsmultiple sclerosisvaccination

Authors and institutions

  • Preventive Medicine and Epidemiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Multiple Sclerosis Centre of Catalonia, Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • CRCSEP Nice, CHU de Nice Pasteur2, Universite ́ Nice Cote d'Azur UR2CA-URRIS, Nice, France.
  • Fundación Santa Fe de Bogotá, Bogotá, Colombia.
  • School of Medicine, Universidad de los Andes, Bogotá, Colombia.
  • Barts and The London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.

ORCID profiles: Susana Otero-Romero, Christine Lebrun-Frénay, Mauricio Farez, Massimo Filippi, Bernhard Hemmer, Melinda Magyari, Celia Oreja-Guevara

Cite

APA

Otero-Romero, S., Lebrun-Frénay, C., Reyes, S., Amato, M. P., Campins, M., Farez, M., Filippi, M., Hacohen, Y., Hemmer, B., Juuti, R., Magyari, M., Oreja-Guevara, C., Siva, A., Vukusic, S., & Tintoré, M. (2023). European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs. European Journal of Neurology, 30(8), 2144-2176. https://doi.org/10.1111/ene.15809

Vancouver

Otero-Romero S, Lebrun-Frénay C, Reyes S, Amato MP, Campins M, Farez M, et al. European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs. European Journal of Neurology. 2023;30(8):2144-2176. doi:10.1111/ene.15809

BibTeX
@article{OteroRomero2023,
  author = {Otero-Romero, Susana and Lebrun-Frénay, Christine and Reyes, Saúl and Amato, Maria Pia and Campins, Magda and Farez, Mauricio and Filippi, Massimo and Hacohen, Yael and Hemmer, Bernhard and Juuti, Rosa and Magyari, Melinda and Oreja-Guevara, Celia and Siva, Aksel and Vukusic, Sandra and Tintoré, Mar},
  title = {European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs},
  journal = {European Journal of Neurology},
  year = {2023},
  volume = {30},
  number = {8},
  pages = {2144--2176},
  doi = {10.1111/ene.15809}
}
Start for free →